25 XP   0   0   10

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
Buy, Hold or Sell?

Let's analyse Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd together

PenkeI guess you are interested in Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

I send you an email if I find something interesting about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

Quick analysis of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (30 sec.)










What can you expect buying and holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥0.04
Expected worth in 1 year
¥-1.94
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
¥-1.82
Return On Investment
-21.6%

For what price can you sell your share?

Current Price per Share
¥8.41
Expected price per share
¥7.27 - ¥8.55
How sure are you?
50%

1. Valuation of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.41

Intrinsic Value Per Share

¥-7.92 - ¥1.45

Total Value Per Share

¥-7.89 - ¥1.49

2. Growth of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (5 min.)




Is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$619k$8.9m-$8.3m-1,341.1%

How much money is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$9.3m-$4.1m-$5.2m-55.9%
Net Profit Margin-62.0%-20.3%--

How much money comes from the company's main activities?

3. Financial Health of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (5 min.)




What can you expect buying and holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? (5 min.)

Welcome investor! Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's management wants to use your money to grow the business. In return you get a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

What can you expect buying and holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd?

First you should know what it really means to hold a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is ¥8.41. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥0.04. Based on the TTM, the Book Value Change Per Share is ¥-0.49 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.08-0.9%-0.08-0.9%-0.03-0.4%-0.02-0.3%-0.01-0.1%
Usd Book Value Change Per Share-0.07-0.8%-0.07-0.8%-0.03-0.4%-0.02-0.3%-0.01-0.1%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share-0.06-0.7%-0.06-0.7%-0.03-0.3%-0.01-0.2%0.000.0%
Usd Price Per Share1.31-1.31-1.24-1.53-1.90-
Price to Earnings Ratio-17.14--17.14--36.70--49.48-452.73-
Price-to-Total Gains Ratio-20.94--20.94--49.55-94.97-98.78-
Price to Book Ratio258.52-258.52-16.94-63.74-44.15-
Price-to-Total Gains Ratio-20.94--20.94--49.55-94.97-98.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.162262
Number of shares860
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.07-0.02
Usd Total Gains Per Share-0.06-0.01
Gains per Quarter (860 shares)-53.97-11.50
Gains per Year (860 shares)-215.88-46.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
119-235-22626-72-56
237-469-44253-145-102
356-704-65879-217-148
475-938-874106-290-194
593-1173-1090132-362-240
6112-1407-1306158-434-286
7131-1642-1522185-507-332
8149-1876-1738211-579-378
9168-2111-1954238-652-424
10187-2345-2170264-724-470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%14.05.04.060.9%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%10.013.00.043.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%22.00.01.095.7%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%5.05.00.050.0%13.010.00.056.5%

Fundamentals of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, as well as Chinese medicine diagnosis and treatment services. In addition, the company engages in the software development, remote health management, commercial complex management, food, Internet information businesses, etc. The company was founded in 1958 and is headquartered in Hangzhou, China.

Fundamental data was last updated by Penke on 2024-04-17 09:29:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of -62.0% means that ¥-0.62 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is -62.0%. The company is making a huge loss. -2
  • The TTM is -62.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-62.0%TTM-62.0%0.0%
TTM-62.0%YOY-20.3%-41.8%
TTM-62.0%5Y-17.7%-44.4%
5Y-17.7%10Y-10.3%-7.4%
1.1.2. Return on Assets

Shows how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • -22.5% Return on Assets means that Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd generated ¥-0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is -22.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.5%TTM-22.5%0.0%
TTM-22.5%YOY-7.4%-15.1%
TTM-22.5%5Y-6.4%-16.1%
5Y-6.4%10Y-3.6%-2.8%
1.1.3. Return on Equity

Shows how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • 0.0% Return on Equity means Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-66.0%+66.0%
TTM-5Y-18.1%+18.1%
5Y-18.1%10Y-10.8%-7.3%

1.2. Operating Efficiency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is operating .

  • Measures how much profit Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-12.4%+12.4%
TTM-5Y-4.8%+4.8%
5Y-4.8%10Y-2.5%-2.3%
1.2.2. Operating Ratio

Measures how efficient Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 2.03 means that the operating costs are ¥2.03 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 2.032. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.032. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.032TTM2.0320.000
TTM2.032YOY1.812+0.220
TTM2.0325Y1.718+0.313
5Y1.71810Y1.497+0.221

1.3. Liquidity of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 0.56 means the company has ¥0.56 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.561. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.561. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.561TTM0.5610.000
TTM0.561YOY0.741-0.180
TTM0.5615Y0.838-0.277
5Y0.83810Y0.621+0.217
1.3.2. Quick Ratio

Measures if Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.14 means the company can pay off ¥0.14 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.139. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.139. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.139TTM0.1390.000
TTM0.139YOY0.205-0.065
TTM0.1395Y0.323-0.184
5Y0.32310Y0.279+0.045

1.4. Solvency of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.99 means that Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd assets are financed with 98.5% credit (debt) and the remaining percentage (100% - 98.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.985. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.985. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.985TTM0.9850.000
TTM0.985YOY0.840+0.145
TTM0.9855Y0.832+0.153
5Y0.83210Y0.788+0.043
1.4.2. Debt to Equity Ratio

Measures if Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 0.0% means that company has ¥0.00 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY7.483-7.483
TTM-5Y4.506-4.506
5Y4.50610Y4.062+0.444

2. Market Valuation of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of -17.14 means the investor is paying ¥-17.14 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The EOD is -15.159. Based on the earnings, the company is expensive. -2
  • The MRQ is -17.142. Based on the earnings, the company is expensive. -2
  • The TTM is -17.142. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.159MRQ-17.142+1.983
MRQ-17.142TTM-17.1420.000
TTM-17.142YOY-36.695+19.553
TTM-17.1425Y-49.479+32.337
5Y-49.47910Y452.727-502.207
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The EOD is -44.749. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -50.602. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -50.602. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-44.749MRQ-50.602+5.853
MRQ-50.602TTM-50.6020.000
TTM-50.602YOY-35.125-15.477
TTM-50.6025Y-11.274-39.328
5Y-11.27410Y-35.755+24.481
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 258.52 means the investor is paying ¥258.52 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd:

  • The EOD is 228.621. Based on the equity, the company is expensive. -2
  • The MRQ is 258.524. Based on the equity, the company is expensive. -2
  • The TTM is 258.524. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD228.621MRQ258.524-29.903
MRQ258.524TTM258.5240.000
TTM258.524YOY16.939+241.585
TTM258.5245Y63.744+194.780
5Y63.74410Y44.148+19.596
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.493-0.4930%-0.236-52%-0.152-69%-0.075-85%
Book Value Per Share--0.0370.0370%0.530-93%0.646-94%0.662-94%
Current Ratio--0.5610.5610%0.741-24%0.838-33%0.621-10%
Debt To Asset Ratio--0.9850.9850%0.840+17%0.832+18%0.788+25%
Debt To Equity Ratio----0%7.483-100%4.506-100%4.062-100%
Dividend Per Share--0.0390.0390%0.055-29%0.056-29%0.052-24%
Eps---0.555-0.5550%-0.245-56%-0.159-71%-0.086-85%
Free Cash Flow Per Share---0.188-0.1880%-0.256+36%0.042-549%-0.073-61%
Free Cash Flow To Equity Per Share---0.188-0.1880%0.028-776%-0.012-93%-0.050-73%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.450--------
Intrinsic Value_10Y_min---7.922--------
Intrinsic Value_1Y_max--0.064--------
Intrinsic Value_1Y_min---0.356--------
Intrinsic Value_3Y_max--0.255--------
Intrinsic Value_3Y_min---1.455--------
Intrinsic Value_5Y_max--0.520--------
Intrinsic Value_5Y_min---2.968--------
Market Cap1024161390.000-13%1158118290.0001158118290.0000%1093575420.000+6%1349798436.000-14%1675191924.000-31%
Net Profit Margin---0.620-0.6200%-0.203-67%-0.177-72%-0.103-83%
Operating Margin----0%-0.1240%-0.0480%-0.0250%
Operating Ratio--2.0322.0320%1.812+12%1.718+18%1.497+36%
Pb Ratio228.621-13%258.524258.5240%16.939+1426%63.744+306%44.148+486%
Pe Ratio-15.159+12%-17.142-17.1420%-36.695+114%-49.479+189%452.727-104%
Price Per Share8.410-13%9.5109.5100%8.980+6%11.084-14%13.756-31%
Price To Free Cash Flow Ratio-44.749+12%-50.602-50.6020%-35.125-31%-11.274-78%-35.755-29%
Price To Total Gains Ratio-18.520+12%-20.943-20.9430%-49.552+137%94.971-122%98.782-121%
Quick Ratio--0.1390.1390%0.205-32%0.323-57%0.279-50%
Return On Assets---0.225-0.2250%-0.074-67%-0.064-72%-0.036-84%
Return On Equity----0%-0.6600%-0.1810%-0.1080%
Total Gains Per Share---0.454-0.4540%-0.181-60%-0.097-79%-0.023-95%
Usd Book Value--619098.452619098.4520%8921928.793-93%10879807.529-94%11140726.413-94%
Usd Book Value Change Per Share---0.068-0.0680%-0.033-52%-0.021-69%-0.010-85%
Usd Book Value Per Share--0.0050.0050%0.073-93%0.089-94%0.091-94%
Usd Dividend Per Share--0.0050.0050%0.008-29%0.008-29%0.007-24%
Usd Eps---0.077-0.0770%-0.034-56%-0.022-71%-0.012-85%
Usd Free Cash Flow---3162945.501-3162945.5010%-4302708.259+36%703797.380-549%-1105969.018-65%
Usd Free Cash Flow Per Share---0.026-0.0260%-0.035+36%0.006-549%-0.010-61%
Usd Free Cash Flow To Equity Per Share---0.026-0.0260%0.004-776%-0.002-93%-0.007-73%
Usd Market Cap141539104.098-13%160051947.678160051947.6780%151132123.044+6%186542143.855-14%231511523.897-31%
Usd Price Per Share1.162-13%1.3141.3140%1.241+6%1.532-14%1.901-31%
Usd Profit---9336831.218-9336831.2180%-4118557.643-56%-2719326.354-71%-1461432.571-84%
Usd Revenue--15050833.94915050833.9490%20324961.556-26%30995221.534-51%26818126.644-44%
Usd Total Gains Per Share---0.063-0.0630%-0.025-60%-0.013-79%-0.003-95%
 EOD+3 -5MRQTTM+0 -0YOY+9 -245Y+3 -3010Y+4 -29

3.2. Fundamental Score

Let's check the fundamental score of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-15.159
Price to Book Ratio (EOD)Between0-1228.621
Net Profit Margin (MRQ)Greater than0-0.620
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.139
Current Ratio (MRQ)Greater than10.561
Debt to Asset Ratio (MRQ)Less than10.985
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.225
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.102
Ma 20Greater thanMa 509.003
Ma 50Greater thanMa 1009.210
Ma 100Greater thanMa 20010.246
OpenGreater thanClose8.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Stockholder Equity 58,23045,767103,997-31,15472,843-27,65945,184-59,811-14,627



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets299,840
Total Liabilities295,360
Total Stockholder Equity-14,627
 As reported
Total Liabilities 295,360
Total Stockholder Equity+ -14,627
Total Assets = 299,840

Assets

Total Assets299,840
Total Current Assets124,133
Long-term Assets175,707
Total Current Assets
Cash And Cash Equivalents 42,392
Net Receivables 30,806
Inventory 47,561
Other Current Assets 381
Total Current Assets  (as reported)124,133
Total Current Assets  (calculated)121,140
+/- 2,993
Long-term Assets
Property Plant Equipment 164,937
Goodwill 2,199
Intangible Assets 5,370
Long-term Assets  (as reported)175,707
Long-term Assets  (calculated)172,505
+/- 3,201

Liabilities & Shareholders' Equity

Total Current Liabilities221,221
Long-term Liabilities74,139
Total Stockholder Equity-14,627
Total Current Liabilities
Short Long Term Debt 104,643
Accounts payable 47,223
Other Current Liabilities 490
Total Current Liabilities  (as reported)221,221
Total Current Liabilities  (calculated)152,355
+/- 68,866
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7,463
Long-term Liabilities Other 1,430
Long-term Liabilities  (as reported)74,139
Long-term Liabilities  (calculated)8,893
+/- 65,246
Total Stockholder Equity
Total Stockholder Equity (as reported)-14,627
Total Stockholder Equity (calculated)0
+/- 14,627
Other
Capital Stock121,779
Common Stock Shares Outstanding 121,779
Net Debt 62,250
Net Invested Capital 90,015
Net Working Capital -97,088
Property Plant and Equipment Gross 244,704



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
405,881
408,746
373,530
346,517
357,853
372,708
352,475
414,089
369,082
328,273
319,794
357,836
295,925
324,584
288,338
280,382
306,193
431,406
464,073
540,843
442,510
402,649
299,840
299,840402,649442,510540,843464,073431,406306,193280,382288,338324,584295,925357,836319,794328,273369,082414,089352,475372,708357,853346,517373,530408,746405,881
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101,292
115,319
207,069
235,227
266,354
222,925
186,075
124,133
124,133186,075222,925266,354235,227207,069115,319101,292000000000000000
       Cash And Cash Equivalents 
110,736
108,613
108,522
36,249
33,026
37,275
61,508
20,703
29,295
39,233
39,945
35,683
18,192
31,557
29,072
6,838
29,841
40,627
86,805
25,696
7,574
22,291
42,392
42,39222,2917,57425,69686,80540,62729,8416,83829,07231,55718,19235,68339,94539,23329,29520,70361,50837,27533,02636,249108,522108,613110,736
       Short-term Investments 
34,340
33,396
0
0
94
95
0
8,330
68
16
253
1,121
0
0
0
0
0
0
0
0
0
0
0
000000000001,12125316688,330095940033,39634,340
       Net Receivables 
90,628
92,247
85,920
140,456
156,731
161,212
108,942
75,360
134,469
62,096
66,412
107,576
53,537
60,552
46,390
25,736
38,915
56,241
77,341
177,590
43,875
51,423
30,806
30,80651,42343,875177,59077,34156,24138,91525,73646,39060,55253,537107,57666,41262,096134,46975,360108,942161,212156,731140,45685,92092,24790,628
       Other Current Assets 
1,390
3,476
3,224
5,898
5,960
2,160
11,272
112,969
26,500
20,971
6,611
7,528
10,447
7,808
3,699
2,812
1,921
52,592
1,705
7,175
6,002
4,679
381
3814,6796,0027,1751,70552,5921,9212,8123,6997,80810,4477,5286,61120,97126,500112,96911,2722,1605,9605,8983,2243,4761,390
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
190,874
224,337
246,846
357,735
219,586
216,573
175,707
175,707216,573219,586357,735246,846224,337190,8740000000000000000
       Property Plant Equipment 
115,106
115,102
123,703
106,716
105,664
113,600
113,361
89,538
92,318
98,304
95,822
96,508
95,878
102,635
116,616
135,044
126,689
145,894
168,622
180,913
200,120
199,815
164,937
164,937199,815200,120180,913168,622145,894126,689135,044116,616102,63595,87896,50895,82298,30492,31889,538113,361113,600105,664106,716123,703115,102115,106
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,024
21,024
21,024
5,644
3,315
2,199
2,1993,3155,64421,02421,02421,02400000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,372
9,351
1,747
1,747
0
0
0
0
00001,7471,7479,3519,372000000000000000
       Intangible Assets 
12,458
12,508
9,583
8,118
9,132
1,974
1,507
995
962
429
379
329
279
229
6,639
8,651
8,467
9,233
52,386
47,989
5,679
5,525
5,370
5,3705,5255,67947,98952,3869,2338,4678,6516,6392292793293794299629951,5071,9749,1328,1189,58312,50812,458
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
190,874
43,060
246,846
54,140
0
0
0
00054,140246,84643,060190,8740000000000000000
> Total Liabilities 
154,596
157,113
120,325
103,878
105,494
133,323
116,036
131,161
128,784
140,532
165,659
175,000
200,252
226,408
200,177
217,626
240,010
334,177
372,515
401,146
349,178
338,091
295,360
295,360338,091349,178401,146372,515334,177240,010217,626200,177226,408200,252175,000165,659140,532128,784131,161116,036133,323105,494103,878120,325157,113154,596
   > Total Current Liabilities 
154,596
157,113
120,325
103,478
104,694
132,523
115,236
128,081
127,984
139,732
164,859
174,200
199,452
196,808
162,842
183,128
201,757
230,497
334,735
204,654
251,887
251,151
221,221
221,221251,151251,887204,654334,735230,497201,757183,128162,842196,808199,452174,200164,859139,732127,984128,081115,236132,523104,694103,478120,325157,113154,596
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,500
86,500
69,900
0
0
0
0
000069,90086,500128,5000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,500
86,500
69,900
38,000
113,387
106,746
104,643
104,643106,746113,38738,00069,90086,500128,5000000000000000000
       Accounts payable 
7,341
11,836
12,825
12,964
11,226
15,988
15,688
19,774
23,240
28,595
13,559
23,798
35,732
49,327
25,454
29,331
18,029
31,548
38,710
56,100
53,463
66,029
47,223
47,22366,02953,46356,10038,71031,54818,02929,33125,45449,32735,73223,79813,55928,59523,24019,77415,68815,98811,22612,96412,82511,8367,341
       Other Current Liabilities 
22,749
32,877
32,100
32,004
27,068
27,135
25,648
48,807
44,394
33,137
56,327
46,420
41,724
45,481
43,388
53,126
38,567
78,174
98,572
70,535
72,246
70,461
490
49070,46172,24670,53598,57278,17438,56753,12643,38845,48141,72446,42056,32733,13744,39448,80725,64827,13527,06832,00432,10032,87722,749
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,253
103,680
57,780
206,565
97,291
86,939
74,139
74,13986,93997,291206,56557,780103,68038,2530000000000000000
       Other Liabilities 
0
0
0
400
800
800
800
800
800
800
800
800
800
29,600
37,335
34,498
38,253
57,680
49,780
151,946
97,291
82,388
0
082,38897,291151,94649,78057,68038,25334,49837,33529,600800800800800800800800800800400000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,287
713
4,261
2,776
6,852
6,888
5,935
0
05,9356,8886,8522,7764,2617131,287000000000000000
> Total Stockholder Equity
226,633
224,372
223,551
212,837
221,141
207,488
206,277
228,074
224,838
172,595
140,691
168,014
79,172
81,280
81,650
57,193
58,970
67,112
58,230
103,997
72,843
45,184
-14,627
-14,62745,18472,843103,99758,23067,11258,97057,19381,65081,28079,172168,014140,691172,595224,838228,074206,277207,488221,141212,837223,551224,372226,633
   Common Stock
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
121,779
0
0121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779121,779
   Retained Earnings 
33,840
31,224
30,252
19,395
23,884
7,215
7,602
21,517
25,597
0
0
0
0
0
0
-115,524
-114,307
-106,165
-117,004
-72,126
-111,832
-141,634
-233,375
-233,375-141,634-111,832-72,126-117,004-106,165-114,307-115,52400000025,59721,5177,6027,21523,88419,39530,25231,22433,840
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
656
0
0
0
0006560000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue116,722
Cost of Revenue-89,234
Gross Profit27,48827,488
 
Operating Income (+$)
Gross Profit27,488
Operating Expense-134,209
Operating Income-17,487-106,721
 
Operating Expense (+$)
Research Development1,946
Selling General Administrative9,247
Selling And Marketing Expenses-
Operating Expense134,20911,193
 
Net Interest Income (+$)
Interest Income58
Interest Expense-7,136
Other Finance Cost-309
Net Interest Income-7,387
 
Pretax Income (+$)
Operating Income-17,487
Net Interest Income-7,387
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-65,429-17,487
EBIT - interestExpense = -7,136
-64,771
-57,635
Interest Expense7,136
Earnings Before Interest and Taxes (EBIT)--58,293
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-65,429
Tax Provision-835
Net Income From Continuing Ops-66,264-66,264
Net Income-64,771
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-7,387
 

Technical Analysis of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The general trend of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 8.31 < 8.45 < 8.55.

The bearish price targets are: 8.07 > 7.95 > 7.27.

Tweet this
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current macd is -0.11615171.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current adx is 23.82.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current sar is 9.90955556.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current rsi is 35.10. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Relative Strength Index (RSI) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Stochastic Oscillator ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current cci is -141.07268616.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Commodity Channel Index (CCI) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current cmo is -39.937277.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current willr is -80.47619048.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Williams %R ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current atr is 0.34803545.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Average True Range (ATR) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current obv is 36,646,190.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily On-Balance Volume (OBV) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. The current mfi is 50.58.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Money Flow Index (MFI) ChartHangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.102
Ma 20Greater thanMa 509.003
Ma 50Greater thanMa 1009.210
Ma 100Greater thanMa 20010.246
OpenGreater thanClose8.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

I send you an email if I find something interesting about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd.

Receive notifications about Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd in your mailbox!